A detailed history of Affinity Asset Advisors, LLC transactions in Pro Mis Neurosciences Inc. stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 30,643 shares of PMN stock, worth $27,885. This represents 0.01% of its overall portfolio holdings.

Number of Shares
30,643
Previous 265,958 88.48%
Holding current value
$27,885
Previous $398,000 90.45%
% of portfolio
0.01%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$1.2 - $2.27 $282,378 - $534,165
-235,315 Reduced 88.48%
30,643 $38,000
Q3 2023

Nov 14, 2023

BUY
$1.52 - $6.19 $404,256 - $1.65 Million
265,958 New
265,958 $526,000

Others Institutions Holding PMN

About ProMIS Neurosciences Inc.


  • Ticker PMN
  • Exchange OTC
  • Description
  • ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...
More about PMN
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.